Diabetes Technology Society

Organization

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1177/19322968221085273 A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
https://doi.org/10.1177/1932296820954163 Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
https://doi.org/10.1177/19322968221110830 Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come?
https://doi.org/10.3803/enm.2021.201 Continuous Glucose Monitoring in the Hospital
https://doi.org/10.1177/19322968211007212 Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies
https://doi.org/10.1177/19322968231191104 A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
https://doi.org/10.1177/19322968221124583 Artificial Intelligence for Predicting and Diagnosing Complications of Diabetes
https://doi.org/10.1177/19322968211042656 Continuous Ketone Monitoring Consensus Report 2021
https://doi.org/10.1111/dom.15636 Risks of peri‐ and postoperative complications with glucagon‐like peptide‐1 receptor agonists
https://doi.org/10.1177/19322968231152236 Update on Measuring Ketones
https://doi.org/10.1177/19322968211043498 Six Digital Health Technologies That Will Transform Diabetes
https://doi.org/10.1177/19322968211009860 Continuous Ketone Monitoring: A New Paradigm for Physiologic Monitoring
https://doi.org/10.1177/19322968241275701 The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors
https://doi.org/10.1177/19322968211022321 Diabetes Technology and Waste: A Complex Story
https://doi.org/10.1177/19322968241291512 Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
https://doi.org/10.1186/s12911-024-02757-z Qualitative metrics from the biomedical literature for evaluating large language models in clinical decision-making: a narrative review
https://doi.org/10.1177/19322968231186575 Use of Continuous Glucose Monitors in the Hospital: The Diabetes Technology Society Hospital Meeting Report 2023
https://doi.org/10.1177/19322968241292041 Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes
https://doi.org/10.1210/clinem/dgad745 Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement
https://doi.org/10.1177/19322968221132252 Painful Diabetic Neuropathy: The Need for New Approaches
https://doi.org/10.1177/19322968251353228 Continuous Glucose Monitoring Data Analysis 2.0: Functional Data Pattern Recognition and Artificial Intelligence Applications
https://doi.org/10.2337/dc24-2522 Quantifying Environmental Waste From Diabetes Devices in the U.S.
https://doi.org/10.1177/19322968251333441 The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
https://doi.org/10.1177/19322968241271304 FDA Interoperability Designation—Creating Options for People With Diabetes and Pump Companies: Regulatory, Technological, and Commercial Perspectives
https://doi.org/10.1177/19322968241296543 Importance of Cybersecurity/The Relevance of Cybersecurity to Diabetes Devices: An Update from Diabetes Technology Society
https://doi.org/10.1177/19322968211058148 The Need for Data Standards and Implementation Policies to Integrate CGM Data into the Electronic Health Record
https://doi.org/10.1177/193229681300700432 Do Currently Available Blood Glucose Monitors Meet Regulatory Standards? 1-Day Public Meeting in Arlington, Virginia
https://doi.org/10.1177/1932296820978399 How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
https://doi.org/10.1177/1932296818763634 Standards for Medical Device Cybersecurity in 2018
https://doi.org/10.1177/19322968221093662 The Launch of the iCoDE Standard Project
https://doi.org/10.1177/19322968231161095 Using ChatGPT to Predict the Future of Diabetes Technology
https://doi.org/10.1016/j.pcad.2023.05.002 Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society
https://doi.org/10.1177/19322968221133795 Spinal Cord Stimulation for Painful Diabetic Neuropathy
https://doi.org/10.1177/19322968211049800 Green Diabetes Summit 2021
https://doi.org/10.1177/19322968231187661 Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society
https://doi.org/10.1177/19322968241287773 Artificial Intelligence to Diagnose Complications of Diabetes
https://doi.org/10.1016/j.eprac.2023.04.006 Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks
https://doi.org/10.1177/19322968231178549 The Need for Data Standards and Implementation Policies to Integrate Insulin Delivery Data Into the Electronic Health Record
https://doi.org/10.1177/19322968211051721 The Diabetes Technology Society Green Declaration
https://doi.org/10.1177/19322968231214281 The Need for a Modern Error Grid for Clinical Accuracy of Blood Glucose Monitors and Continuous Glucose Monitors
https://doi.org/10.1177/19322968231201829 NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption
https://doi.org/10.1016/j.eprac.2022.12.016 A Roadmap to an Equitable Digital Diabetes Ecosystem
https://doi.org/10.1177/19322968231200847 Use of Continuous Glucose Monitors Upon Hospital Discharge of People With Diabetes: Promise, Barriers, and Opportunity
https://doi.org/10.1177/193229680900300521 Performance Analysis of the OneTouch® UltraVue™ Blood Glucose Monitoring System
https://doi.org/10.1177/19322968231171399 Remote Digital Technologies for the Early Detection and Monitoring of Cognitive Decline in Patients With Type 2 Diabetes: Insights From Studies of Neurodegenerative Diseases
https://doi.org/10.1177/19322968211046326 Noninvasive Glucose Monitoring: In God We Trust—All Others Bring Data
https://doi.org/10.1177/19322968231186626 Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis
https://doi.org/10.1177/19322968211041328 Antioxidant-Induced Pseudohyperglycemia Due to Interference of Measurements by Blood Glucose Monitors
https://doi.org/10.37765/ajmc.2023.89422 Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes
https://doi.org/10.1177/19322968221139514 A Newly FDA-Cleared Benchtop Glucose Analyzer Heralds the Dawn of the Post–YSI 2300 Era
https://doi.org/10.1177/19322968211018186 Benefits of Conformity Assessment for Cybersecurity Standards of Diabetes Devices and Other Medical Devices
https://doi.org/10.1177/19322968241227898 Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes
https://doi.org/10.1177/19322968241235205 Diabetes Technology Meeting 2023
https://doi.org/10.1177/19322968241268235 Principles of Interoperability of Diabetes Devices
https://doi.org/10.1177/19322968241306129 How the Diabetes Research Hub Will Modernize and Enhance Diabetes Data Utilization
https://doi.org/10.1210/jendso/bvaf088 Glucagon-Like Peptide-1 Receptor Agonists and Peri-Procedural Aspiration Risk
https://doi.org/10.1177/19322968251365245 Machine Learning to Diagnose Complications of Diabetes
https://doi.org/10.1177/19322968231155422 Barriers and Solutions to Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin From 1988 to 2020
https://doi.org/10.1177/19322968251368908 Batteries in Diabetes Technology Devices and Recycling: Need for Eco-Design
https://doi.org/10.1177/19322968241309357 How to Provide Additional Oversight to Ensure That Remote Patient Monitoring for People With Diabetes is Being Used and Billed Appropriately
https://doi.org/10.1038/s41746-025-01720-0 The need to transition from paper to electronic instructions for use for diabetes devices
https://doi.org/10.1177/19322968251391819 Research Code Sharing in Support of Gold Standard Science
https://doi.org/10.1177/1932296821999080 Advances in Insulin Pump Infusion Sets Symposium Report
https://doi.org/10.1177/19322968211015241 Digital Connectivity: The Sixth Vital Sign
https://doi.org/10.1177/1932296820973185 Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes
https://doi.org/10.1016/j.jksus.2020.09.002 Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
https://doi.org/10.1177/1932296820939626 Hospital Diabetes Meeting 2020
https://doi.org/10.1177/19322968221090279 Diabetes Technology Meeting 2021
https://doi.org/10.1177/19322968221119146 iCoDE June 22, 2022 Steering Committee Meeting Summary Report
https://doi.org/10.1177/19322968211024268 The Need for Sharps Waste Disposal Guidelines for Commercial Airports
https://doi.org/10.1177/19322968231207888 The Launch of the iCoDE-2 Standard Project: Integration of Connected Diabetes Device Data Into the Electronic Health Record
https://doi.org/10.1177/19322968241240436 Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia
https://doi.org/10.1177/1357633x231184503 Twenty-first century management of diabetes with shared telemedicine appointments
https://doi.org/10.1109/bhi58575.2023.10313421 Joint Embedding of Food Photographs and Blood Glucose for Improved Calorie Estimation
https://doi.org/10.1177/19322968241296541 Advanced Glycation End Products (AGEs) Webinar Meeting Report
https://doi.org/10.1177/19322968241280386 Time to Moderate and Severe Hyperglycemia and Ketonemia Following an Insulin Pump Occlusion
https://doi.org/10.1177/193229680900300224 Insulin Pump Safety Meeting: Summary Report
https://doi.org/10.1177/1932296819872107 Digital Diabetes Congress 2019
https://doi.org/10.1177/19322968221127253 Telehealth Fatigue: Is It Real? What Should Be Done?
https://doi.org/10.1177/19322968221078884 Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report
https://doi.org/10.1177/1932296821993498 Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency
https://doi.org/10.1177/19322968241288923 The Benefits of Using Continuous Glucose Monitoring to Diagnose Type 1 Diabetes
https://doi.org/10.1177/1932296814549680 Hospital Diabetes Meeting
https://doi.org/10.1177/19322968221148743 Diabetes Technology Meeting 2022
https://doi.org/10.1016/j.heliyon.2023.e18440 Temporal changes in bio-behavioral and glycemic outcomes following a produce prescription program among predominantly Hispanic/Latino adults with or at risk of type 2 diabetes
https://doi.org/10.1177/19322968221081888 Treating an Unconscious Patient With Diabetes Wearing a Device Attached to Their Body
https://doi.org/10.1177/19322968221110878 Hospital Diabetes Meeting 2022
https://doi.org/10.1177/19322968231184448 Diabetes Research and Resource Sharing During the COVID-19 Pandemic: A Systematic Review and Experience from an Academic/Non-Profit Resource Website
https://doi.org/10.1177/19322968211016480 Diabetes Technology Meeting 2020
https://doi.org/10.3389/fdgth.2021.720530 Digital Health Approaches for Improved Population Health Outcomes: Time for a Disease Vulnerability Matrix for Individuals and Communities?
https://doi.org/10.1177/19322968221105895 Retained Diabetes Devices—A Literature Review
https://doi.org/10.1016/j.diabres.2024.111940 Comparison of the glycemia risk index and time in range in a case series of using automated insulin delivery to improve glycemic control in people with type 1 diabetes and end stage kidney disease on hemodialysis
https://doi.org/10.1007/s11428-024-01257-y Umwelt, Klima und Diabetes: ein internationales Thema
https://doi.org/10.1016/j.diabres.2025.112307 Diabetes devices: a growing environmental burden
https://doi.org/10.1177/193229681100500201 Self-Monitoring of Blood Glucose and Type 2 Diabetes: New Tricks for the Old Dog?
https://doi.org/10.1177/1932296818805632 Digital Diabetes Congress 2018
https://doi.org/10.1177/19322968211033611 Input of Patients for New Diabetes Technology Products
https://doi.org/10.1177/19322968231155165 Real-World Evidence Supports Higher Prevalence of Heart Failure Among Persons With Type 1 and Type 2 Diabetes Compared With the General Population
https://doi.org/10.1177/193229681300700501 Freedom of Speech and Science: Can Companies Force Us to Withdraw Data They Don't Like?
https://doi.org/10.1177/19322968221100196 Trimetazidine Blocks Lipid Oxidation—Should it be Repurposed for Prevention and Treatment of Diabetic Ketoacidosis?